Product news
-
27/11/2019
Endoret® (PRGF®) rewrites the way of treating patients
Endoret® (PRGF®) is a 100 % endogenous technology, based on platelet-enriched plasma obtained from patient’s own blood. The high regenerative potential and versatility make Endoret® (PRGF®) a MUST for a wide range of clinical applications.
-
16/05/2019
Join the SQUARE prosthetic evolution
The perfect smile is the result of a series of successful prosthodontic decisions in terms of the design, techniques and fabrication materials of dental prostheses.
-
26/02/2019
NEW BTI APNIA - a simplified and efficient system for the diagnosis and treatment of sleep apnoea and snoring
The new BTI Apnia electronic device, due to its design and functionality, tops the list of the most simplified respiratory polygraphs on the market.
-
15/11/2018
New therapeutic alternative for the rehabilitation of narrow alveolar ridges
BTI Biotechnology Institute proposes a minimally invasive alternative for this surgical treatment: the new family of 3.0 implants
-
13/09/2018
Shorten the restoration times with BTI® solutions
More and more scientific studies are revealing the predictability of immediate loaded short implants. Thus, the development by BTI® of a series of surgical-prosthetic concepts, resulting in a protocol that uses short implants, front cutting drills and Multi – Im® transepithelial abutments enables the execution, with better results, of the immediate loading technique in multiple restorations
-
19/06/2018
Preservation of the post-extraction socket using Endoret® (PRGF®) technology
BTI Biotechnology Institute is the pioneering company leading the market in the development of tissue regeneration techniques through the therapeutic use of plasma rich in growth factors.